Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 has been added to the study record history. It indicates an update to the page version and supersedes the previous v3.6.2 entry.
    Difference
    0.1%
    Check dated 2026-07-04T03:59:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A frontend revision label was updated from Revision: v3.6.0 to Revision: v3.6.2 in the page history. This reflects a UI/version update behind the study record history rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:00:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer looking for participants, and the revision history now shows a new version (v3.6.0) replacing the previous v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-12T16:43:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry labeled Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This change updates the study record's history metadata on the Record History page.
    Difference
    0.1%
    Check dated 2026-06-05T13:26:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The release notes now reflect the site version as v3.5.4, replacing the prior v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T06:51:27.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page’s footer version/revision label has been updated from 3.5.2 to 3.5.3, reflecting a maintenance/release update with no apparent change to the study’s recorded information.
    Difference
    0.1%
    Check dated 2026-04-24T05:42:38.000Z thumbnail image

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.